Using Methods from PFDD Guidance 1 and Guidance 2 as Tools for Including Patient Experience Data in Clinical Trials: Who to Ask and How to Ask - 06/30

[FDA]

The Food and Drug Administration (FDA) is announcing a series of two public meetings entitled “Using Methods from PFDD Guidance 1 and Guidance 2 as Tools for Including Patient Experience Data in Clinical Trials: Who to Ask and How to Ask.


Baca selengkapnya di : http://www.fda.gov...